YURISAN RIOS: Open Payments
NPI 1578948501 · HIALEAH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$885 in 43 payments from 15 companies in 2025. Trend: 2023 $143 · 2024 $321 · 2025 $885
Food & beverage: $885
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 10 | $162 |
| Ipsen Biopharmaceuticals, Inc | 4 | $115 |
| Lilly USA, LLC | 4 | $88 |
| ABBVIE INC. | 4 | $82 |
| Intercept Pharmaceuticals, Inc. | 3 | $79 |
| Braintree Laboratories, Inc. | 3 | $54 |
| Phathom Pharmaceuticals, Inc. | 5 | $50 |
| Madrigal Pharmaceuticals | 1 | $50 |
| GENZYME CORPORATION | 1 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
Products named: IBSRELA, IQIRVO, OMVOH, OCALIVA, VOQUEZNA, REZDIFFRA, CREON, DUPIXENT.
Industry payments across FL — which companies pay providers there.
